참고문헌 (29)

1. Wehrle PF. Smallpox eradication. A global appraisal.JAMA 1978; 240(18): 1977-1979 

   상세보기

2. Minor PD. Biosafety consequences of eradication of wild-type polioviruses. Lancet 2001; 358(9277): 166-168 

   상세보기

3. 김용익, 박기동, 임정수, 황유성, 생물테러 가능 병원체와 실험실에 대한 안전등급제 도입 및 운영방안 개발. 국립보권원. 생물 테러대비 두창백신 희석 활용 및 집단예방 접종 방안 개발. 2003 

4. 남명진. 안전관련 법령 제정 방안. 이의경. 생명과학관련 국민보건안전윤리 확보방안. 2000년 보건의료기술개발사업 정책연구개발사업보고서. 보건복지부 2001 

5. Orellana C. Laboratory-acquired SARS raises worries on biosafety. Lancet Infect Dis 2004; 4(2): 64 

6. Kissalt A. Laboratoriums infektionen mit typhusbazillen. Zeit Hyg Infectionkrank 1915; 80: 145-162 

   상세보기

7. Meyer KF, Eddie B. Laboratory infections due to brucella. J Infect Dis 1941; 68: 24-32 

   

8. Reid DD. Incidence of tuberculosis among workers in medical laboratories. Br Med J 1957; 2: 10-14 

   

9. Grist NR. Hepatitis in clinical laboratories a three year survey. J Clin Pathol 1975; 28: 255-259 

   상세보기

10. Grist NR. Hepatitis in clinical laboratories 1973-1974. J Clin Pathol 1976; 29: 480-483 

    상세보기

11. Grist NR. Hepatitis in clinical laboratories 1975-1976. J Clin Pathol 1978; 31: 415-417 

    상세보기

12. Richrdson JH. Provisional summary of 109 laboratory-associated infections at the Center for Disease Control, 1947-1973. Presented at the 16th Annual Biosafety Conference, Ames, Iowa. 1973 

13. Martini GA, Schmidt HA. Spermatogenic transmission of Marburg viruus. Klin Wschr 1968; 46: 398-400 

    상세보기

14. Oliphant JW, Parker RR. Q fever: Three cases of laboratory infection. Public Health Rep 1948; 63(42): 1364-1370 

    상세보기

15. Beeman EA. Q fever-An epidemiological note. Public Health Rep 1950; 65(2): 88-92 

    상세보기

16. Holmes GP, Hilliard JK, KLontz KC, Rupert AH, Schindler CM, Parrish E, Griffin DG, Ward GS, Bernstein ND, Bean TW, Ball MR, Bready JA, Wilder MH, Kaplan JE. B virus(Herpesvirus simiae) infection in humans: epidemiologic investigation of a cluster. Ann Int Med 1990; 112: 833-839 

    상세보기

17. Her majesty's stationary office. Report of the committee of inquiry into smallpox outbreakin London in march and April 1973. London. 1974 

18. World Health Organization. Smallpox surveillance. Weekly Epidemiol Record 1978; 53(35): 265-266 

19. WHO. Laboratory biosafety mannual. 2nd edition(revised). Geneva. 2003 

20. CDC and NIH. Biosafety in microbiological and biomedical laboratories. 4th edition.Washington. 1999 

21. Advisory Committee on Dangerous Pathogens. Categorization of biological agents accordingto hazard and categories of containment. 4th edition. London. 1995 

22. Office of Laboratory Security. The laboratory biosafety guidelines. 3th edition(draft).Ottawa. 2001 

23. Lee HW, Johnson KM. Laboratory-acquired infections with hantaan virus, the etiologicagent of Korean hemmorrhagic fever. J Infec Dis 1982; 146; 645-651 

    상세보기

24. Kim JS, Lee HW. Studies on microbiololgical laboratory biosafety (1) a survey on biosafety status in laboratory department of training. Report NIH Korea 1986; 23: 139-160 (Korean) 

25. Cho SH, Ju YS, Kang D, Kim S, Kim IS, Hong ST. Laboratory-acquired infection with hantavirus at a research unit of medical school in Seoul, 1996. Korean J Prev Med 1999; 32(3): 269-275 (Korean) 

26. 보건복지부. 유전자재조합실험지침 보건복지부고시 제1997-22호. 보건복지부; 1996 

27. Sulkin SE, Pike RM. Survey of laboratoryacquired infections. Am J Public Health 1951; 41(7): 769-781 

    상세보기

28. Sung WK. Development of the system ensuring biosafety in genetic modification experiment. Health and Welfare Policy Forum 2001; 4: 45-58 (Korean) 

29. 보건복지부. 전염병병원체 검사. 보존 및 관리 지침, 보건복지부 고시 2001-25호. 보건복지부; 2001 

저자의 다른 논문 :

은상준 (7) 황유성 (3) 김용익 (56)